An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
AUTOR(ES)
Motomura, M
RESUMO
A new immunoprecipitation assay has been established for detecting antibodies to voltage-gated calcium channels (VGCCs) in Lambert-Eaton myasthenic syndrome (LEMS), using 125I-omega-conotoxin MVIIC, which binds to P-type VGCCs, to label extracts of human cerebellum. Fifty six of 66 serum samples (85%) from patients with clinically and electrophysiologically definite LEMS were positive for the presence of VGCC antibodies, defined as a titre > 3 SD above the mean for the healthy controls (n = 10). All disease controls (n = 40) were negative. This sensitive immunoassay should prove valuable in the diagnosis of LEMS.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1073275Documentos Relacionados
- Congenital Lambert-Eaton myasthenic syndrome.
- Respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome.
- Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome.
- Increased amplitude of F-response in Lambert-Eaton myasthenic syndrome.
- Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome.
